EENT · PANCE / PANRE

Allergic Conjunctivitis

IgE-mediated bilateral ocular itching, redness, and watery discharge — frequently with allergic rhinitis.

Also known as: allergic conjunctivitis, seasonal allergic conjunctivitis, perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis

Overview

Bilateral IgE-mediated inflammation of the conjunctiva caused by environmental allergens. Forms: seasonal (SAC, pollen) and perennial (PAC, dust mite/animal/mold) — most common; vernal keratoconjunctivitis (VKC) — pediatric, atopic, severe with corneal involvement; atopic keratoconjunctivitis (AKC) — adult, chronic, sight-threatening; giant papillary conjunctivitis (GPC) — related to contact lenses or ocular prostheses.

Epidemiology

Affects 15-40% of the population in some form. Often coexists with allergic rhinitis, asthma, and eczema. VKC is most common in male children 5-15 in warm climates; AKC affects adults with atopic dermatitis.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Allergic Conjunctivitis outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Personal or family history of atopy (asthma, eczema, food allergy, allergic rhinitis)
  • Exposure to seasonal allergens (pollen) or year-round allergens (dust mite, mold, pet dander)
  • Contact lens wear (GPC)
  • Warm dry climate (VKC)
  • Childhood (VKC)

Pathophysiology

Allergen exposure cross-links IgE bound to conjunctival mast cells, causing degranulation with histamine, tryptase, prostaglandins, and leukotrienes. Early phase: itching, tearing, redness within minutes. Late phase: eosinophil infiltrate hours later → chemosis and persistent symptoms. VKC and AKC have additional Th2-driven chronic inflammation with eosinophils.

Clinical presentation

Symptoms

  • BILATERAL itching — the hallmark; 'I want to rub my eyes constantly'
  • Watery or stringy mucoid discharge
  • Redness, burning, foreign body sensation
  • Eyelid swelling and chemosis
  • Concurrent nasal symptoms (sneezing, congestion) — allergic rhinoconjunctivitis
  • Triggered by pollens, animal dander, dust

Signs / physical exam

  • Diffuse conjunctival hyperemia and chemosis (clear gelatinous swelling)
  • Papillary reaction on tarsal conjunctiva (giant papillae in VKC, AKC, GPC)
  • Watery or ropy mucus discharge
  • Mild eyelid edema
  • Allergic shiners
  • VKC: limbal Horner-Trantas dots, shield ulcer on cornea — sight-threatening
  • AKC: lichenified eyelid skin, keratoconus, cataracts in chronic disease

Classic findings

Bilateral itching with chemosis and watery stringy discharge in an atopic patient.

Differential diagnosis

  • Viral conjunctivitis — Watery discharge, preauricular adenopathy, recent URI, follicular reaction; itching mild
  • Bacterial conjunctivitis — Purulent discharge, eyelids matted shut, no itching
  • Dry eye disease — Burning, foreign body sensation, worse end of day, fluorescein punctate staining, low tear film breakup time; artificial tears, cyclosporine
  • Blepharitis — Eyelid margin scaling, telangiectasias, crusting; lid hygiene
  • Contact dermatitis of eyelid — Erythema and scaling of lid skin, history of allergen exposure (cosmetics, drops); topical steroid to lid
  • Toxic conjunctivitis — Recent topical drop or preservative exposure; resolves with cessation
  • Giant papillary conjunctivitis (GPC) — Contact lens wearer with itching, mucus, large papillae on upper tarsus; lens hygiene change

Diagnostic workup

Labs

  • Clinical diagnosis based on history and exam
  • Allergy testing (skin prick or specific IgE) if persistent or trigger unclear
  • Conjunctival scraping rarely needed — would show eosinophils

Imaging

  • Slit-lamp examination for chemosis, papillae, and corneal involvement
  • Fluorescein staining if corneal symptoms — exclude shield ulcer or punctate keratitis

Diagnostic algorithm

SubtypePopulationKey FeaturesRisk
Seasonal allergic conjunctivitis (SAC)Atopic, all agesPollen-triggered, itching, chemosisLow — symptomatic
Perennial allergic conjunctivitis (PAC)Year-round atopicDust mite/pet/mold-triggeredLow — symptomatic
Vernal keratoconjunctivitis (VKC)Boys 5-15, warm climateCobblestone tarsal papillae, Horner-Trantas dots, shield ulcerSight-threatening (shield ulcer, keratoconus)
Atopic keratoconjunctivitis (AKC)Adults with atopic dermatitisChronic, eyelid lichenification, corneal scarringSight-threatening; keratoconus, cataract
Giant papillary conjunctivitis (GPC)Contact lens wearersItching, mucus, giant tarsal papillaeLens intolerance
Subtypes of allergic conjunctivitis with distinguishing features and risk.

Treatment

First-line

  • Allergen avoidance — close windows during high pollen counts, wash hands and face after exposure, dust mite covers, pet dander measures
  • Cold compresses to reduce itching and swelling
  • Artificial tears (preservative-free preferred) to dilute and wash allergens
  • Topical ophthalmic antihistamine/mast cell stabilizer — olopatadine 0.1-0.7%, ketotifen 0.025%, alcaftadine, bepotastine — combined agents are first-line for moderate-severe disease
  • Topical mast cell stabilizer alone — cromolyn, lodoxamide, nedocromil — slower onset, useful prophylactically
  • Oral 2nd-generation antihistamine (loratadine, cetirizine, fexofenadine) if concurrent allergic rhinitis

Second-line / adjunct

  • Topical NSAIDs (ketorolac) — short-term symptom relief
  • Topical corticosteroids — short course (1-2 weeks) under ophthalmologist supervision for severe acute flares; monitor IOP and cataract formation
  • Topical calcineurin inhibitors (cyclosporine 0.05-0.1%, tacrolimus) — VKC/AKC and steroid-sparing chronic cases
  • Allergen immunotherapy (SCIT or SLIT) — particularly when concurrent allergic rhinitis warrants disease modification
  • Ophthalmology referral for VKC, AKC, shield ulcer, GPC unresponsive to lens change, or steroid dependence

Complications

  • Chronic eye rubbing → keratoconus (especially in VKC/AKC)
  • Corneal shield ulcer in VKC (sight-threatening)
  • Cataract and glaucoma from chronic topical steroid use
  • Secondary bacterial infection from rubbing
  • Reduced quality of life, sleep disruption, school/work impairment

PANCE pearls

  • BILATERAL ITCHING is the hallmark of allergic conjunctivitis — without itching, look elsewhere.
  • Topical olopatadine (antihistamine + mast cell stabilizer) is the workhorse — once-daily 0.7% formulation has good efficacy.
  • AVOID prolonged topical corticosteroids without ophthalmology supervision — cataract, glaucoma, and HSV reactivation risk.
  • Topical decongestant drops (naphazoline, tetrahydrozoline) cause rebound hyperemia with chronic use — discourage.
  • VKC and AKC are sight-threatening atopic phenotypes — refer to ophthalmology; treat eye rubbing to prevent keratoconus.
  • Contact lens wearer with itching + mucus + giant papillae = giant papillary conjunctivitis — change lens type/material or discontinue.

References

  • AAO 2018 — American Academy of Ophthalmology. Conjunctivitis Preferred Practice Pattern. Ophthalmology 2019;126(1):P94-P169
  • AAAAI 2020 — Bielory L et al. ICON: Diagnosis and Management of Allergic Conjunctivitis. Ann Allergy Asthma Immunol 2020;124(2):118-134

Practice EENT questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.